All Stories

  1. Warning labels for sugar-sweetened beverages and fruit juice: evaluation of 27 different labels on health effects, sugar content, energy and exercise equivalency
  2. Medication-based Comorbidity Measures and Prostate Cancer Treatment Selection
  3. Primary, allied health, selected specialists, and mental health service utilisation by home care recipients in Australia before and after accessing the care, 2017–2019
  4. Primary health care service utilisation before and after entry into long-term care in Australia
  5. Utility of prescription-based comorbidity indices for predicting mortality among Australian men with prostate cancer
  6. Mental Health Service Contact Following Cancer Diagnosis and Associations with Cancer Mortality: Results from a Linked Population-Based Study of Adolescents and Young Adults in New South Wales
  7. Prognostic value of comorbidity measures among Australian men with non-metastatic prostate cancer
  8. Risk of secondary malignancy following radiation therapy for prostate cancer
  9. Reporting Real-World Data on Prostate Cancer Treatment Outcomes to Consumers: The Prostate Cancer Report Card
  10. Demographic, health, and prognostic characteristics of Australians with liver cancer: a cohort study of linked data in New South Wales for informing cancer control
  11. The fraction of life years lost after diagnosis (FLYLAD): a person-centred measure of cancer burden
  12. REPCAN: Guideline for REporting Population-based CANcer Registry Data
  13. The effect of general practice contact on cancer stage at diagnosis in Aboriginal and non-Aboriginal residents of New South Wales
  14. Development of the consensus-based recommendations for Podiatry care of Neuropathy In Cancer Survivors (PodNICS): a Delphi consensus study of Australian podiatrists
  15. Variations in colorectal cancer pattern of care by age and comorbidity in South Australia
  16. Primary, allied health, geriatric, pain and palliative healthcare service utilisation by aged care residents, 2012–2017
  17. Associations of advanced age with comorbidity, stage and primary subsite as contributors to mortality from colorectal cancer
  18. Pregnancy‐associated gynecological cancer in New South Wales, Australia 1994–2013: A population‐based historical cohort study
  19. Increased Early Cancer Diagnosis: Unveiling Immune-Cancer Biology to Explain Clinical “Overdiagnosis”
  20. Pregnancy associated cancer, timing of birth and clinical decision making—a NSW data linkage study
  21. Long-term benefits for lower socioeconomic groups by improving bowel screening participation in South Australia: A modelling study
  22. “No Child or Adult Would Ever Probably Choose to Have 16 Teaspoons of Sugar”: A Preliminary Study of Parents’ Responses to Sugary Drink Warning Label Options
  23. Occurrence of comorbidity with colorectal cancer and variations by age and stage at diagnosis
  24. Second Primary Cancers Following Cancer Among Adolescents and Young Adults in Queensland, Australia, 1982–2018
  25. Multi-jurisdictional Prostate Cancer Registry Linkage.
  26. Interval cancers as related to frequency of recall to assessment in the South Australian population-based breast screening program: An exploratory study
  27. Impact of relational continuity of primary care in aged care: a systematic review
  28. “You can’t just eat 16 teaspoons of sugar so why would you drink 16 teaspoons’ worth of sugar?”: a qualitative study of young adults’ reactions to sugary drink warning labels
  29. The potential for tailored screening to reduce bowel cancer mortality for Aboriginal and Torres Strait Islander peoples in Australia: Modelling study
  30. Antibiotic exposure six months preceding systemic therapy was associated with lower cancer survival
  31. Body image and quality of life in women with breast cancer: Appreciating the body and its functionality
  32. Variations in utilisation of colorectal cancer services in South Australia indicated by MBS/PBS benefits: a benefit incidence analysis
  33. Changes in five‐year survival for people with acute leukaemia in South Australia, 1980–2016
  34. Warning labels and interpretive nutrition labels: Impact on substitution between sugar and artificially sweetened beverages, juice and water in a real-world selection task
  35. Challenges for ethics committees in biomedical research governance: Illustrations from China and Australia
  36. Factors involved in treatment decision making for women diagnosed with ductal carcinoma in situ: A qualitative study
  37. Associations between breast cancer screening participation and residential area sociodemographic features, geographic accessibility, and features of screening venue location in Greater Sydney, Australia
  38. Investigating the breast cancer screening–treatment–mortality pathway of women diagnosed with invasive breast cancer: Results from linked health data
  39. Prognostic Differences of RAS Mutations: Results from the South Australian Metastatic Colorectal Registry
  40. Regorafenib outcomes from the population based South Australian Metastatic Colorectal Cancer Registry
  41. Cancer Profiles, Times to Treatment, and Survival for Adolescents and Young Adults: Comparisons with Children and Older Adults in New South Wales, Australia
  42. Residential Area Sociodemographic and Breast Cancer Screening Venue Location Built Environmental Features Associated with Women’s Use of Closest Venue in Greater Sydney, Australia
  43. The premature mortality to incidence ratio (PREMIER): a person-centred measure of cancer burden
  44. Sharing Government Health Data With the Private Sector: Community Attitudes Survey
  45. Cohort profile: indigenous human papillomavirus and oropharyngeal squamous cell carcinoma study - a prospective longitudinal cohort
  46. Carcinosarcomas of the Uterus: Prognostic Factors and Impact of Adjuvant Treatment
  47. Overdiagnosis of screen‐detected breast cancer
  48. Residential area and screening venue location features associated with spatial variation in breast cancer screening invitation response rates: an observational study in Greater Sydney, Australia
  49. Degree of Cancer Spread at Presentation and Survival Among Adolescents and Young Adults in New South Wales, Australia
  50. Female breast cancer treatment and survival in South Australia: Results from linked health data
  51. Breast cancer treatment and survival differences in women in remote and socioeconomically disadvantaged areas, as demonstrated by linked data from New South Wales (NSW), Australia
  52. Female breast cancer in New South Wales, Australia, by country of birth: implications for health-service delivery
  53. Intentions to reduce sugar-sweetened beverage consumption: the importance of perceived susceptibility to health risks
  54. Measuring psychosocial outcomes of men living with prostate cancer: feasibility of regular assessment of patient‐reported outcomes
  55. Late mortality in people with cancer: a population‐based Australian study
  56. The Impact of Cancer on Early Childhood Development: A Linked Data Study
  57. A randomised online experimental study to compare responses to brief and extended surveys of health-related quality of life and psychosocial outcomes among women with breast cancer
  58. An In-Depth Exploration of Knowledge and Beliefs Associated with Soda and Diet Soda Consumption
  59. Sharing Government Health Data With the Private Sector: Community Attitudes Survey (Preprint)
  60. Young‐onset colorectal cancer is associated with a personal history of type 2 diabetes
  61. Optimal care pathways: A national policy to improve quality of cancer care and address inequalities in cancer outcomes
  62. Female breast cancer in New South Wales, Australia, by country of birth: implications for health-service delivery
  63. Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancer
  64. Cancers of the corpus uteri treated in South Australian public hospitals: Trends in clinical management and survival across three decades
  65. Engagement of General Practice in an Australian Organised Bowel Cancer Screening Program: A Cross-Sectional Survey of Knowledge and Practice
  66. Nothing beats taste or convenience: a national survey of where and why people buy sugary drinks in Australia
  67. Prevalence of Oral Human Papillomavirus Infection Among Australian Indigenous Adults
  68. Monitoring TNM stage of female breast cancer and survival across the South Australian population, with national and international TNM benchmarking: A population-based cohort study
  69. Consumption of Sugar-Sweetened Beverages, Juice, Artificially-Sweetened Soda and Bottled Water: An Australian Population Study
  70. Overdiagnosis of cancer in Australia: the role of screening
  71. History of screening by BreastScreen New South Wales of women with invasive breast cancer
  72. Treatment and outcomes of metastatic colorectal cancer patients in public and private hospitals: Results from the South Australian Metastatic Colorectal Cancer Registry
  73. Effect of mammography screening and sociodemographic factors on stage of female breast cancer at diagnosis in New South Wales
  74. Differences in breast cancer treatment pathways for women participating in screening through BreastScreen New South Wales
  75. Breast Cancer Incidence and Survival Among Young Females in Queensland, Australia
  76. Estimating the lifetime risks of cancer: the best measure depends on your purpose
  77. A population-based study of soft tissue sarcoma incidence and survival in Australia: An analysis of 26,970 cases
  78. Optimizing the measurement of comorbidity for a South Australian colorectal cancer population using administrative data
  79. Cancer treatment and the risk of cancer death among Aboriginal and non-Aboriginal South Australians: analysis of a matched cohort study
  80. Mix Design and Mechanical Properties of Rubberized Cement Stabilized Soil (RCSS) Pavers
  81. Time from diagnosis to treatment of colorectal cancer in a South Australian clinical registry cohort: how it varies and relates to survival
  82. Pre-diagnostic colonoscopies reduce cancer mortality - results from linked population-based data in South Australia
  83. Patterns of comorbidities in women with breast cancer: a Canadian population-based study
  84. The burden of cancer on primary and secondary health care services before and after cancer diagnosis in New South Wales, Australia
  85. Disparities in breast screening, stage at diagnosis, cancer treatment and the subsequent risk of cancer death: a retrospective, matched cohort of aboriginal and non-aboriginal women with breast cancer
  86. The effects of comorbidity on colorectal cancer mortality in an Australian cancer population
  87. Differences in cancer incidence by age at diagnosis between Aboriginal and non-Aboriginal people for cancer types included in Australian national screening programs
  88. Are Australians ready for warning labels, marketing bans and sugary drink taxes? Two cross-sectional surveys measuring support for policy responses to sugar-sweetened beverages
  89. “ When we were young, it really was a treat; now sugar is just the norm every day ” — A qualitative study of parents’ and young adults’ perceptions and consumption of sugary drinks
  90. Metastasectomy and BRAF mutation: An analysis of survival outcome in metastatic colorectal cancer.
  91. Type 2 diabetes as a potential risk marker for early onset colorectal cancer.
  92. Accounting for Immigrant Status when Calculating Cancer Incidence Rates for Bangkok
  93. Extent and predictors of grade upgrading and downgrading in an Australian cohort according to the new prostate cancer grade groupings
  94. Evaluation of an intervention to train health professionals working with Aboriginal and Torres Strait Islander people to provide smoking cessation advice
  95. Exploring the added value of hospital-registry data for showing local service outcomes: cancers of the ovary, fallopian tube and peritoneum
  96. Sugar-sweetened beverage (SSB) consumption, correlates and interventions among Australian Aboriginal and Torres Strait Islander communities: a scoping review
  97. Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry
  98. Who drinks sugar sweetened beverages and juice? An Australian population study of behaviour, awareness and attitudes
  99. Patterns of health service utilisation among the Australian population with cancer compared with the general population
  100. The Use of Travel Time to Measure Geographic Accessibility to Breast Screening Services in New South Wales, Australia Short Paper
  101. Breast Screen Service Characteristics as a Measure of Accessibility
  102. Aboriginal women have a higher risk of cervical abnormalities at screening; South Australia, 1993–2016
  103. Developing a comorbidity index for comparing cancer outcomes in Aboriginal and non-Aboriginal Australians
  104. Using hospital registries in Australia to extend data availability on vulval cancer treatment and survival
  105. Has cancer survival improved for older people as for younger people? New South Wales, 1980–2012
  106. The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern
  107. Keratinocyte cancers in South Australia: incidence, geographical variability and service trends
  108. Human Papillomavirus and Oropharyngeal Cancer Among Indigenous Australians: Protocol for a Prevalence Study of Oral-Related Human Papillomavirus and Cost-Effectiveness of Prevention
  109. Changes in the prevalence of comorbidity in the Australian population with cancer, 2007–2014
  110. Australian Adolescents and Young Adults: Trends in Cancer Incidence, Mortality, and Survival Over Three Decades
  111. Do we know what to do with our nonagenarian and centenarian patients with metastatic colorectal cancer (mCRC)? Results from the South Australian mCRC registry
  112. Comorbidity and cervical cancer survival of Indigenous and non-Indigenous Australian women: A semi-national registry-based cohort study (2003-2012)
  113. Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study
  114. Diabetes and smoking as predictors of cancer in Indigenous adults from rural and remote communities of North Queensland - A 15-year follow up study
  115. Comorbidities contribute to the risk of cancer death among Aboriginal and non-Aboriginal South Australians: Analysis of a matched cohort study
  116. Outcomes for metastatic colorectal cancer (mCRC) based on microsatellite instability.
  117. The impact of primary tumour resection and sidedness in patients with synchronous metastatic colorectal cancer (mCRC): Findings from the South Australian Metastatic Colorectal Cancer Registry (SAMCRC).
  118. Comorbidities in Australian women with hormone-dependent breast cancer: a population-based analysis
  119. Incidence of Comorbidities in Women with Breast Cancer Treated with Tamoxifen or an Aromatase Inhibitor: An Australian Population-Based Cohort Study
  120. Development of Indicators to Assess Quality of Care for Prostate Cancer
  121. Tools for Predicting Clinical and Patient-reported Outcomes in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Systematic Review of Prognostic Accuracy and Validity
  122. “Prostate cancer is far more hidden…”: Perceptions of stigma, social isolation and help-seeking among men with prostate cancer
  123. Barriers and facilitators for health professionals referring Aboriginal and Torres Strait Islander tobacco smokers to the Quitline
  124. Heart failure following blood cancer therapy in pediatric and adult populations
  125. Female breast cancer management and survival: The experience of major public hospitals in South Australia over 3 decades-trends by age and in the elderly
  126. Cancer epidemiology in the small nations of Pacific Islands
  127. Optimum Tools for Predicting Clinical Outcomes in Prostate Cancer Patients Undergoing Radical Prostatectomy: A Systematic Review of Prognostic Accuracy and Validity
  128. Human papillomavirus infection and intrauterine growth restriction: a data-linkage study
  129. Reply to ‘Comment on ‘Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study’’
  130. The value of local registry data for describing cervical cancer management and outcomes over three decades in Australia
  131. Cancer survival disparities worsening by socio-economic disadvantage over the last 3 decades in new South Wales, Australia
  132. Bevacizumab first line and impact on subsequent anti-EGFR activity
  133. Sugar-sweetened beverage consumption, correlates and interventions among Australian Aboriginal and Torres Strait Islander communities: a scoping review protocol
  134. Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity
  135. After accounting for competing causes of death and more advanced stage, do Aboriginal and Torres Strait Islander peoples with cancer still have worse survival? A population-based cohort study in New South Wales
  136. Disparities in cancer stage at diagnosis and survival of Aboriginal and non-Aboriginal South Australians
  137. Does exclusion of cancers registered only from death-certificate information diminish socio-demographic disparities in recorded survival?
  138. Patient-Reported Outcomes After Radiation Therapy in Men With Prostate Cancer: A Systematic Review of Prognostic Tool Accuracy and Validity
  139. Bevacizumab and its impact on survival for patients receiving subsequent anti-EGFR therapy: Updated results from the SA metastatic CRC registry.
  140. The outcome of patients (pts) with metastatic colorectal cancer (mCRC) based on site of metastases (mets) and the impact of molecular markers and site of primary cancer on metastatic pattern.
  141. Australian validation of the Cancer of the Prostate Risk Assessment Post-Surgical score to predict biochemical recurrence after radical prostatectomy
  142. Use of guideline‐recommended adjuvant therapies and survival outcomes for people with colorectal cancer at tertiary referral hospitals in South Australia
  143. Findings in young adults at colonoscopy from a hospital service database audit
  144. Cancer survivorship monitoring systems for the collection of patient-reported outcomes: a systematic narrative review of international approaches
  145. PD47-11 OPTIMUM TOOLS FOR PREDICTING CLINICAL OUTCOMES IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY: A SYSTEMATIC REVIEW OF PROGNOSTIC ACCURACY AND VALIDITY
  146. Comorbidity, physical and mental health among cancer patients and survivors: An Australian population-based study
  147. An appraisal of analytical tools used in predicting clinical outcomes following radiation therapy treatment of men with prostate cancer: a systematic review
  148. Assessing impact of organised breast screening across small residential areas-development and internal validation of a prediction model
  149. Variations in outcomes for Indigenous women with breast cancer in Australia: A systematic review
  150. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999–2011
  151. Time to clinical investigation for Indigenous and non-Indigenous Queensland women after a high grade abnormal Pap smear, 2000–2009
  152. Bevacizumab and its impact on survival for patients receiving subsequent anti-EGFR therapy: Results from the South Australian metastatic colorectal cancer registry.
  153. Nonagenarian patients with metastatic colorectal cancer: Results from the South Australian metastatic colorectal cancer registry.
  154. Patterns of care for synchronous rectal cancer with liver-only metastasis: Results from the South Australian registry of metastatic colorectal cancer.
  155. Administrative data provide vital research evidence for maximizing health-system performance and outcomes
  156. Pancreatectomy is underused in NSW regions with low institutional surgical volumes: a population data linkage study
  157. Cancer registration challenges in low- and middle-income countries-the case of the Pacific Islands
  158. History, development and future of cancer screening in Australia
  159. The impact of geographic unit of analysis on socioeconomic inequalities in cancer survival and distant summary stage – a population‐based study
  160. Cancer Data and Aboriginal Disparities (CanDAD)—developing an Advanced Cancer Data System for Aboriginal people in South Australia: a mixed methods research protocol
  161. High quality data are the key to understanding inequalities in cancer outcomes for Aboriginal and Torres Strait Islander Australians
  162. Heart failure following cancer treatment: characteristics, survival and mortality of a linked health data analysis
  163. Prevalence of Comorbidities and Health Status among Current Cancer and Cancer Survivors: An Australian Population-Based Study
  164. Brain metastasis in advanced colorectal cancer: Results from the South Australian metastatic colorectal cancer (SAmCRC) registry
  165. Breast cancer screening-opportunistic use of registry and linked screening data for local evaluation
  166. Prostate cancer outcomes for men who present with symptoms at diagnosis
  167. A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease
  168. Short-term outcomes after surgical resection for colorectal cancer in South Australia
  169. Characteristics of patients with haematological and breast cancer (1996–2009) who died of heart failure‐related causes after cancer therapy
  170. Validation of administrative hospital data for identifying incident pancreatic and periampullary cancer cases: a population-based study using linked cancer registry and administrative hospital data in New South Wales, Australia
  171. Colorectal cancer treatment and survival over three decades at four major public hospitals in South Australia: trends by age and in the elderly
  172. Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry
  173. The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000‐2011)
  174. Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000–2011
  175. Differences in impact of Aboriginal and Torres Strait Islander status on cancer stage and survival by level of socio-economic disadvantage and remoteness of residence—A population-based cohort study in Australia
  176. The utility of linked cancer registry and health administration data for describing system-wide outcomes and research: a BreastScreen example
  177. Metastatic Colorectal Cancer in Young Adults: A Study From the South Australian Population-Based Registry
  178. Cancer Data and Aboriginal Disparities Project (CanDAD) - an overdue cancer control initiative
  179. Development of an International Prostate Cancer Outcomes Registry
  180. Survival improvements associated with access to biological agents: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registry
  181. Socio-demographic disadvantage and distant summary stage of cancer at diagnosis—A population-based study in New South Wales
  182. Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset
  183. Recent advances of sonodynamic therapy in cancer treatment
  184. BRAF Mutation Testing and Metastatic Colorectal Cancer in the Community Setting: Is There an Urgent Need for More Education?
  185. Sociodemographic disparities in survival from colorectal cancer in South Australia: a population-wide data linkage study
  186. Metastatic Colorectal Cancer Treatment and Survival: the Experience of Major Public Hospitals in South Australia Over Three Decades
  187. 2163 BRAF testing in the community setting; are we testing enough given the importance of BRAF mutation and the clinical implications?
  188. Comparable survival outcome of metastatic colorectal cancer in Indigenous and non-Indigenous patients: Retrospective analysis of the South Australian metastatic colorectal cancer registry
  189. Death Analysis of a Cohort of Blood, Lymphatic Cancer and Breast Cancer Patients Who Have Developed Heart Failure Following Cancer Treatment
  190. Risk profile of breast cancer following atypical hyperplasia detected through organized screening
  191. Abstracts of poster presentations
  192. Survival impact of primary tumor resection in patients (pts) with unresectable metastatic colorectal cancer (mCRC): Findings from the South Australian Metastatic Colorectal Cancer Registry (SAMCRC).
  193. Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects
  194. Breast Cancer Characteristics and Survival Differences between Maori, Pacific and other New Zealand Women Included in the Quality Audit Program of Breast Surgeons of Australia and New Zealand
  195. Colorectal Cancer Treatment and Survival: the Experience of Major Public Hospitals in South Australia over three Decades
  196. Translation from clinical trials to routine practice: How to demonstrate community benefit
  197. Performance Indices of Needle Biopsy Procedures for the Assessment of Screen Detected Abnormalities in Services Accredited by BreastScreen Australia
  198. Survival for patients with resectable lung metastatic colorectal cancer (mCRC).
  199. Changing roles of population-based cancer registries in Australia
  200. Rising incidence of early-onset colorectal cancer in Australia over two decades: Report and review
  201. A qualitative investigation of knowledge, beliefs and attitudes regarding sugar-sweetened beverages, including responses to potential regulatory measures aimed at curbing obesity
  202. Estimating over-diagnosis of breast cancer (Authors' Reply)
  203. Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?
  204. Colorectal cancer screening and subsequent incidence of colorectal cancer: results from the 45 and Up Study
  205. Monitoring approval of new legislation banning smoking in children's playgrounds and public transport stops in South Australia: Table 1
  206. Equivalence of outcomes for rural and metropolitan patients with metastatic colorectal cancer in South Australia
  207. What factors are predictive of surgical resection and survival from localised non-small cell lung cancer?
  208. Breast cancer survival in New Zealand women
  209. Realising opportunities for evidence-based cancer service delivery and research: linking cancer registry and administrative data in Australia
  210. Does Exact Primary Site Impact on Outcome for Metastatic Colorectal Cancer (Mcrc)?
  211. A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening
  212. Development and Validation of a Risk Score Predicting Risk of Colorectal Cancer
  213. Cardiotoxicity following Cancer Treatment: Linked Health Data Analysis
  214. Influence of Service Characteristics on High Priority Performance Indicators and Standards in the BreastScreen Australia Program
  215. Colorectal Cancer Survival: An Analysis of Patients With Metastatic Disease Synchronous and Metachronous With the Primary Tumor
  216. Treatment patterns among colorectal cancer patients in South Australia: a demonstration of the utility of population-based data linkage
  217. Patterns of care and outcomes for young patients (age < 40) with metastatic colorectal cancer (mCRC): Findings from a population-based registry.
  218. Survival improvements associated with access to biologic agents: Results from the South Australian (SA) Metastatic Colorectal (mCRC) Registry.
  219. Survival outcomes for patients with metastatic colorectal cancer (mCRC) based on primary site, right (R) colon versus left (L) colon versus rectal (Rec) primary: Results from the South Australian Registry of mCRC.
  220. Influence of Mammographic Screening on Breast Cancer Incidence Trends in South Australia
  221. What Roles should Population-based Cancer Registries be Playing in the 21st Century? Reflections on the Asian Cancer Registry Forum, Bangkok, February 2014
  222. Trends in migrant mortality rates in Australia 1981–2007: a focus on the National Health Priority Areas other than cancer
  223. A systematic review of surgical biopsy for LCIS found at core needle biopsy – Do we have the answer yet?
  224. Cancer survival for Aboriginal and Torres Strait Islander Australians: a national study of survival rates and excess mortality
  225. Right (R) or left (L) primary site of colorectal cancer and outcomes for metastatic colorectal cancer (mCRC): Results from the south Australian registry of mCRC.
  226. Analysing risk factors for poorer breast cancer outcomes in residents of lower socioeconomic areas of Australia
  227. The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®
  228. Factors predictive of immediate breast reconstruction following mastectomy for invasive breast cancer in Australia
  229. Do breast cancer risk factors differ among those who do and do not undertake mammography screening?
  230. Can cancer registries show whether treatment is contributing to survival increases for melanoma of the skin at a population level?
  231. Do metastatic colorectal cancer patients who present with late relapse after curative surgery have a better survival?
  232. Impact of hormone replacement therapy use on mammographic screening outcomes
  233. Factors Predictive of Treatment by Australian Breast Surgeons of Invasive Female Breast Cancer by Mastectomy rather than Breast Conserving Surgery
  234. Risk Factors for Poorer Breast Cancer Outcomes in Residents of Remote Areas of Australia
  235. A population-based study of metastatic colorectal cancer in individuals aged ≥80 years
  236. Estimating prevalence of distant metastatic breast cancer: a means of filling a data gap
  237. Age effects on survival from early breast cancer in clinical settings in Australia
  238. Incidence of metastatic breast cancer in an Australian population-based cohort of women with non-metastatic breast cancer at diagnosis
  239. Impact of age on choice of chemotherapy and outcome in advanced colorectal cancer
  240. Adherence to Recommended Treatments for Early Invasive Breast Cancer: Decisions of Women Attending Surgeons in the Breast Cancer Audit of Australia and New Zealand
  241. Survival From Synchronous Bilateral Breast Cancer: The Experience of Surgeons Participating in the Breast Audit of the Society of Breast Surgeons of Australia and New Zealand
  242. Trends in cancer mortality rates among migrants in Australia: 1981–2007
  243. A review of community engagement in cancer control studies among Indigenous people of Australia, New Zealand, Canada and the USA
  244. Mammography screening and breast cancer mortality in Australia: an aggregate cohort study
  245. Breast Screening and Breast Cancer Survival in Aboriginal and Torres Strait Islander Women of Australia
  246. Survival from breast cancer: an analysis of Australian data by surgeon case load, treatment centre location, and health insurance status
  247. What factors affect the odds of NSW cancer patients presenting with localised as opposed to more advanced cancer?
  248. Estimating cancer incidence in Indigenous Australians
  249. Small Cell Lung Cancer: Patterns of care and their influence on survival - 25 years experience of a single Australian oncology unit
  250. An analysis of the effect of stage at diagnosis of bowel cancer on survival: Findings from the South Australian Clinical Registry (SACR) for metastatic colorectal cancer (mCRC).
  251. Impact of watching prior to commencement of chemotherapy for metastatic colorectal cancer (mCRC): Findings from the South Australian Clinical Registry (SACR) for mCRC.
  252. Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort
  253. A population-based study of metastatic colorectal cancer (mCRC) in people age 80 and older: Findings from the South Australian Clinical Registry (SACR) for mCRC.
  254. Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment? - Yes
  255. Outcomes of lymphoma in South Australia, 1977-2007
  256. South Australian clinical registry for metastatic colorectal cancer
  257. Survival from breast cancers managed by surgeons participating in the National Breast Cancer Audit of the Royal Australasian College of Surgeons
  258. Variation in the management of early breast cancer in rural and metropolitan centres: Implications for the organisation of rural cancer services
  259. Epidemiology of neuroendocrine cancers in an Australian population
  260. Review Paper: The Health Status of Migrants in Australia: A Review
  261. PROPOSALS FOR EPIDEMIOLOGICAL SURVEILLANCE OF OCCUPATIONAL HEALTH IN AUSTRALIA
  262. IMMUNIZATION STATUS OF SOUTH AUSTRALIAN CHILDREN BY SOCIOECONOMIC STATUS AND ETHNICITY
  263. MONITORING CASE SURVIVAL BY HISTOLOGICAL TYPE FOR LUNG CANCER, BREAST CANCER AND NON-HODGKIN'S LYMPHOMAS - ONE FUNCTION OF A POPULATION-BASED REGISTRY
  264. A PERSPECTIVE OF THE CANCER PROBLEM IN SOUTH AUSTRALIA
  265. Patterns of Surgical Treatment for Women with Breast Cancer in Relation to Age
  266. Clinical and socio-demographic profile of an Australian multi-institutional prostate cancer cohort
  267. Bladder cancer survivals in New South Wales, Australia: why do women have poorer survival than men?
  268. Variations in care for operable breast cancer and outcomes between rural and metropolitan centers in Australia
  269. Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for research and cancer control
  270. Reasons for Improved Survival From Ovarian Cancer in New South Wales, Australia, Between 1980 and 2003
  271. Patient and carer perceptions of cancer care in South Australia
  272. Management and Survival Trends in Advanced Colorectal Cancer
  273. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care
  274. TRENDS IN SURGICAL TREATMENT OF YOUNGER PATIENTS WITH BREAST CANCER IN AUSTRALIA AND NEW ZEALAND
  275. Survival and degree of spread for female breast cancers in New South Wales from 1980 to 2003: implications for cancer control
  276. COMMENTARY: HOW SURGICAL AUDITS CAN BE USED TO PROMOTE THE UPDATE OF SURGICAL EVIDENCE
  277. A case–control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women
  278. Prognosis of sub-types of cancer of unknown primary (CUP) compared to metastatic cancer
  279. Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia
  280. Benchmarking epidemiological characteristics of cervical cancer in advance of change in screening practice and commencement of vaccination
  281. Treatment and survival from breast cancer: the experience of patients at South Australian teaching hospitals between 1977 and 2003
  282. Endometrial cells as a predictor of uterine cancer
  283. A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program
  284. Clinical and pathological factors predictive of lymph node status in women with screen-detected breast cancer
  285. Tobacco and alcohol-related mortality in men: estimates from the Australian cohort of petroleum industry workers
  286. Survival trends for advanced colorectal cancer (CRC): Are improvements only for patients in clinical trials?
  287. Prognostic importance of palpability as a feature of screen-detected breast cancers
  288. Factors predictive of preferred place of death in the general population of South Australia
  289. Update of mortality and cancer incidence in the Australian petroleum industry cohort
  290. Asbestos-Related Cancers in Refinery Workers in the Australian Petroleum Industry
  291. Treatment and Survival from Colorectal Cancer: The Experience of Patients at South Australian Teaching Hospitals Between 1980 and 2002
  292. Multiple primary cancers of separate organ sites: implications for research and cancer control (Australia)
  293. Does emotional support influence survival? Findings from a longitudinal study of patients with advanced cancer
  294. Female breast cancers are getting smaller, but socio-demographic differences remain
  295. Detection by screening mammography is a powerful independent predictor of survival in women diagnosed with breast cancer
  296. Time trends in lung cancer incidence by histology in South Australia: likely causes and public health implications
  297. A critical analysis of reasons for improved survival from invasive cutaneous melanoma
  298. Effects of variations in hysterectomy status on population coverage by cervical screening
  299. Risk of cancer in patients with scleroderma: a population based cohort study
  300. Use of radiotherapy in the primary treatment of cancer in South Australia
  301. Cervical cancer: effect of glandular cell type on prognosis, treatment, and survival
  302. The epidemiology of gastric cancer
  303. Issues of consent and privacy affecting the functioning of ASERNIP-S
  304. The coverage of cancer patients by designated palliative services: a population-based study, South Australia, 1999
  305. Tumour location and prognostic characteristics as determinants of survival of women with invasive breast cancer: South Australian hospital-based cancer registries, 1987–1998
  306. An analysis of factors associated with interval as opposed to screen-detected breast cancers, including hormone therapy and mammographic density
  307. LIP CANCER IN SOUTH AUSTRALIA, 1977–1996
  308. Lip cancer in South Australia, 1977–1996
  309. Somatic mutations, acetylator status, and prognosis in colorectal cancer
  310. Rehospitalisation for asthma within 12 months: unequal rates on the basis of gender at two hospitals
  311. Trends in perinatal characteristics in South Australia, 1981 to 1994, by place of residence of mother
  312. Near-fatal asthma in South Australia:descriptive features and medication use
  313. Perinatal mortality trends among South Australian Aboriginal births 1981–92
  314. Characteristics of near-fatal asthma in childhood
  315. Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression.
  316. Trends in prostate cancer incidence and mortality rates in South Australia, 1977‐1993
  317. Brain cancer incidence, mortality and case survival: Observations from two australian cancer registries
  318. Near fatal asthma attacks: the reliability of descriptive information collected from close acquaintances.
  319. Evaluation of the lead Decontamination programme in the leading smelting town of port Pirie (South Australia)
  320. Trends in the terminal care of cancer patients: South Australia, 1981-1990
  321. Birthweight‐Specific Trends in Perinatal Mortality by Hospital Category in South Australia, 1985–1990
  322. Breech Presentation in South Australia, 1987–1989
  323. The association of low socio-economic status in metropolitan adelaide with maternal demographic and obstetric characteristics and pregnancy outcome
  324. Factors Predictive of Corneal Graft Survival
  325. The Association of Maternal and Socioeconomic Characteristics in Metropolitan Adelaide with Medical, Obstetric and Labour Complications and Pregnancy Outcomes
  326. The South Australian Cancer Registry: a means of assessing cancer incidence, mortality and case survival
  327. Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA
  328. Radon daughter exposures at the Radium Hill uranium mine and lung cancer rates among former workers, 1952?87
  329. Case‐survival rates for infiltrating ductal carcinomas by category of hospital at diagnosis in South Australia
  330. Epidemiological characteristics of Legionella infection in South Australia: implications for disease control
  331. Malignant astrocytoma in South Australia: treatment and case survival
  332. Pregnancy and perinatal factors associated with persistently low apgar scores: An analysis of the birth records of infants born in South Australia
  333. Actuarial predictions from population‐based disease registries with unidentified random losses
  334. Infiltrating ductal carcinoma of the breast in South Australia
  335. Epidemiological features of melanoma in South Australia: implications for cancer control (for editorial comment, see page 490)
  336. Pregnancy and birth risk factors for intellectual disability in South Australia
  337. Cervical Cancer in South Australia: Trends in Incidence, Mortality and Case Survival
  338. The use of State and hospital‐based cancer‐registry data to describe the epidemiological and clinical characteristics of laryngeal cancer in South Australia
  339. Cancer case‐survival rates for South Australia: a comparison with US rates and a preliminary investigation of time trends
  340. Obstetric Profiles of Immigrant Women from Non-English Speaking Countries in South Australia, 1981–1983
  341. Professionally defined dental treatment needs of middle-aged and older patients attending 21 general practitioners, as related to tooth retention
  342. Determinants of the microbiological characteristics of spa pools in South Australia
  343. The dental health and treatment needs of middle-aged and older patients attending 21 general dental practitioners in South Australia
  344. Children's Blood Lead Levels in the Lead Smelting Town of Port Pirie, South Australia
  345. Melanoma case survival rates in South Australia by histological type, thickness and level of tumour at diagnosis
  346. Blood lead levels in children in the north‐west of Adelaide
  347. A Nine Year Retrospective Mortality Study of Workers in a British Pharmaceutical Company
  348. Increased tolerance to complete dentures after surgical modification of mylohyoid ridges
  349. Mortality from influenza and allied infections in South Australia during 1968‐1981
  350. Promotion of breast self‐examination in South Australia: A short‐term evaluation
  351. Determinants of case survival for cancers of the lung, colon, breast and cervix in South Australia
  352. Epidemiological surveillance of occupational health in Australia
  353. The association of naegleria fowleri with the chemical, microbiological and physical characteristics of South Australian water supplies
  354. Oral cancer in South Australia-incidence and case survival
  355. A Comparison of Australian Suicide Rates in 1969–73 and 1976–80
  356. Infiltrating ductal carcinoma of the breast in South Australia Sizes of primary lesions and histological evidence of axillary nodal metastases
  357. Byssinosis: A Cross-Sectional Study in an Australian Textile Factory
  358. Population‐based comparative study of campylobacter and salmonella enteritis in South Australia
  359. Survival of South Australian cancer patients
  360. Fluoridation II: An interim economic analysis
  361. The dental health status of children not included by parents in the South Australian School Dental Programme. A pilot study
  362. DENTAL HEALTH EDUCATION
  363. Fluoridation 1. Effects on children's caries rates and professionally defined requirements for dental care
  364. Assessing the effectiveness of dental health education in the South Australian School Dental Programme
  365. Saliva-based colorimetric test as an index of gingival inflammation in epidemiologic studies
  366. THE EMPLOYMENT OF DENTAL NURSES
  367. EVALUATION OF DENTAL HEALTH EDUCATION IN A SCHOOL DENTAL CARE PROGRAM
  368. The effect of a pilot dental health education programme on high school students
  369. The sealing of fissures in a school dental programme
  370. The effect of treatment provided by dentists and therapists in the South Australian school dental service. The second report
  371. Tooth loss in South Australia
  372. The treatment of first permanent molars in a school dental programme: Implications for fissure sealants
  373. Tooth loss, the wearing of dentures and the demand for dental care in the south-east of South Australia
  374. Diagnosis, treatment planning and referral by school dental therapists
  375. The effect of treatment provided by dentists and therapists in the South Australian School Dental Service
  376. The association between dental caries and the availability of sweets in South Australian school canteens
  377. THE SCHOOL DENTAL THERAPIST OF SOUTH AUSTRALIA
  378. The dental health of South Australian country children
  379. The dental health and habits of South Australian children from different socio-economic environments
  380. The South Australian school canteen programme: An interim report
  381. A study of dental knowledge and behaviour in 1,000 Australian schoolchildren